Viewing Study NCT01852604


Ignite Creation Date: 2025-12-24 @ 7:52 PM
Ignite Modification Date: 2025-12-30 @ 12:04 AM
Study NCT ID: NCT01852604
Status: COMPLETED
Last Update Posted: 2015-04-23
First Post: 2013-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module